164
Participants
Start Date
November 30, 2021
Primary Completion Date
August 4, 2023
Study Completion Date
September 30, 2024
Setmelanotide
SC injection
Placebo
SC injection
Mount Sinai, New York
Columbia University, New York
Ten's Medical Center - Pediatric Endocrinology Clinic, Staten Island
Geisinger Clinic, Danville
The Children's Hospital of Philadelphia, Philadelphia
University of North Carolina, Chapel Hill
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital Fundación Jimenez Díaz, Madrid
InQuest Medical Reseacrh, Suwanee
Mississippi Center for Advanced Medicine, Madison
Hospital General de Valencia, Valencia
University of Michigan, Ann Arbor
Metro Detroit Endocrinology Center, Dearborn
Mayo Clinic, Rochester
Endocrine Associates of Dallas and Plano, Dallas
Texas Children's Hospital, Houston
Accurate Clinical Research, Houston
Javara Research, The Woodlands
Clinical Trials of Texas, San Antonio
Rio Grande Valley Endocrine Center, McAllen
Texas Tech, Amarillo
Hector Granados PA, El Paso
HonorHealth Bariatric Center, Scottsdale
Universitaetsklinikum Ulm, Ulm
Chaim Sheba MC, Safra Children's Hospital, Ramat Gan
UMass Memorial Medical Center, Worcester
University of Alberta, Edmonton
Charite - Universitatsmedizin Berlin, Berlin
University of Patras School of Medicine, Pátrai
Bristol Royal Hospital for Children, Bristol
University of Cambridge, Cambridge
Universitaetsklinikum Leipzig, Leipzig
Erasmus Medisch Centrum, Rotterdam
Hospital Sant Joan de Deu, Barcelona
London Medical - The London Diabetes Centre, London
University College London Hospitals NHS Foundation Trust, London
Rhythm Pharmaceuticals, Inc.
INDUSTRY